Sino Biopharmaceutical
1177.HK
#2065
Rank
NZ$13.29 B
Marketcap
$0.73
Share price
-0.62%
Change (1 day)
14.95%
Change (1 year)
Sino Biopharmaceutical is a company based on Hong Kong that does R&D, production and sales of pharmaceuticals.

Revenue for Sino Biopharmaceutical (1177.HK)

Revenue in 2021 (TTM): NZ$5.54 Billion

According to Sino Biopharmaceutical's latest financial reports the company's current revenue (TTM ) is NZ$6.81 Billion. In 2020 the company made a revenue of NZ$4.75 Billion a decrease over the revenue in the year 2019 that were of NZ$5.20 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Sino Biopharmaceutical from 2011 to 2021

Annual revenue

Year Revenue Change
2021 (TTM) NZ$5.54 B16.42%
2020 NZ$4.75 B-8.48%
2019 NZ$5.20 B11.43%
2018 NZ$4.66 B50.13%
2017 NZ$3.10 B1.15%
2016 NZ$3.07 B8.85%
2015 NZ$2.82 B38.25%
2014 NZ$2.04 B32.87%
2013 NZ$1.53 B18.67%
2012 NZ$1.29 B38.62%
2011 NZ$0.93 B